Cerus Corporation

CERS

$2.57

-1.15%

N/A-$0.03

Healthcare

Medical - Devices

NASDAQ

Active Trading

Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the ...

Financial Highlights of CERS

Profitability trend

Latest / TTM · 6 periods

Gross Margin

52.0%

Net Margin

-3.1%

P/E Ratio

-71.53x

n/a

Debt / Equity

1.10

n/a

Current Ratio

1.83

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

52.0%

Net Margin

-3.1%

P/E Ratio

-71.53x

Debt / Equity

1.10

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	51.5%	53.7%	55.3%	55.2%	54.5%	—
Operating MarginOperating income as a percentage of revenue.	-37.4%	-21.0%	-19.2%	-7.9%	-4.2%	—
Net MarginNet income as a percentage of revenue.	-41.6%	-26.4%	-24.0%	-11.6%	-7.6%	—
EBITDA MarginEBITDA divided by revenue.	-35.1%	-20.7%	-16.8%	-5.6%	-2.7%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	-41.3%	-26.1%	-23.9%	-11.5%	-7.4%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	2.38	1.45	2.14	2.39	1.73	—
Quick RatioLiquid assets divided by current liabilities.	2.04	1.21	1.55	1.79	1.17	—
Cash RatioCash and equivalents divided by current liabilities.	0.62	0.30	0.17	0.32	0.20	—
Debt / AssetsDebt as a share of total assets.	36.9%	40.0%	48.5%	48.8%	43.7%	—
Debt / EquityDebt compared with shareholder equity.	1.04	1.29	1.82	1.75	1.51	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	5.21x	4.71x	4.40x	6.05x	6.79x	—
Inventory TurnoverHow often inventory is sold in a year.	2.37x	2.58x	1.75x	2.12x	1.67x	—
Payables TurnoverHow often payables are paid in a year.	1.78x	2.27x	2.93x	3.72x	3.35x	—
Asset TurnoverRevenue generated per dollar of assets.	0.55x	0.74x	0.79x	0.90x	0.93x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	1.13x	2.01x	2.41x	2.18x	2.54x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-21.28x	-15.21x	-10.29x	-14.00x	-25.12x	—
P/B RatioPrice paid for each dollar of book value.	13.78x	9.53x	7.40x	5.06x	6.11x	—
P/S RatioPrice paid for each dollar of sales.	8.91x	3.98x	2.49x	1.58x	1.90x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-33.49x	-23.33x	-8.15x	33.35x	46.07x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer